ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1343

Gingival Bleeding and Periodontitis in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Cohort Study

Takefumi Furuya1, Eisuke Inoue2, Shigeru Maeda3, Eiichi Tanaka1, Katsunori Ikari1, Ayako Nakajima1, Atsuo Taniguchi1 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Division of Medical Informatics, St. Marianna University School of Medicine, Kawasaki, Japan, 3Department of Dental Anesthesiology, Okayama University Hospital, Okayama, Japan

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Anti-resorptives, Japanese, Osteoporosis and rheumatoid arthritis (RA), Periodontitis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster II: Pathophysiology, Autoantibodies, and Disease Activity Measures

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Oral health is an important issue for patients with rheumatoid arthritis (RA) because periodontitis is a potential risk factor for RA and RA patients have been reported to have a significantly increased incidence of periodontitis compared to healthy individuals. We previously reported that 40% of Japanese RA patients disclosed receiving dental treatment in the previous 6 months (J Bone Miner Metab, 2017; 35: 344-350). Limited data exist in the literature concerning periodontitis in Japanese RA patients. This study aimed to evaluate periodontitis in our Institute of Rheumatology Rheumatoid Arthritis (IORRA) cohort.

Methods: The IORRA cohort was established in 2000 as a single institute-based large cohort of Japanese RA patients. More than 122 publications have described various characteristics of Japanese RA patients using this cohort. Patients with RA enrolled in the IORRA cohort completed self-administered questionnaires as part of the 2016 October/November IORRA surveys, which included gingival bleeding during tooth brushing and periodontitis diagnosed by dentists in the previous 6 months (April to September 2016). Logistic regression analyses were used to evaluate associations between gingival bleeding during tooth brushing, periodontitis, and clinical variables.

Results: Among 5,660 Japanese patients with RA who participated in the cohort (median age, 62 years old; females, 86%), 31% and 18% reported having gingival bleeding during tooth brushing and periodontitis diagnosed by a dentist, respectively, in the previous 6 months. Among 1,211 patients with RA treated with anti-resorptive drugs (bisphosphonates and denosumab) (median age, 69 years old; females, 95%), 26% and 19% reported having gingival bleeding during tooth brushing and periodontitis diagnosed, respectively, in the previous 6 months. Among Japanese patients with RA, younger age, ever-smoker status, disease activity score (DAS) 28, and Japanese health assessment questionnaire disability index (JHAQ-DI) were significantly associated with gingival bleeding during tooth brushing, and older age, female sex, ever-smoker status, DAS28, and JHAQ-DI were significantly correlated with periodontitis (Table). Among Japanese RA patients treated with anti-resorptive drugs, younger age and patient general visual analogue scale (VAS) were significantly associated with gingival bleeding during tooth brushing, and older age was associated with periodontitis diagnosis in the previous 6 months.

Conclusion: In Japanese patients with RA, many patients experienced gingival bleeding during tooth brushing and were diagnosed with periodontitis by dentists. Age, female sex, ever-smoker status, general health status, disease activity, and disability may be associated with peridontitis in Japanese patients with RA.

Table. Factors associated with gingival bleeding during tooth brushing and periodontitis

Gingival bleeding during
tooth brushing

Periodontitis diagnosis

Variables

All patients

Patients receiving anti-resorptive

drugs

All patients

Patients receiving anti-resorptive

drugs

Age, per 10 years

0.70 (0.66-0.74)

0.66 (0.57-0.76)

1.26 (1.17-1.36)

1.23 (1.04-1.47)

Female sex

1.07 (0.87-1.33)

—

1.37 (1.04-1.80)

—

Ever smokers

1.17 (1.01-1.36)

—

1.34 (1.11-1.61)

General VAS,
10 cm

—

1.07 (1.01-1.14)

—

—

DAS28

1.15 (1.04-1.27)

—

1.22 (1.08-1.38)

—

JHAQ-DI

1.34 (1.20-1.49)

—

1.15 (1.01-1.31)

—

Odds ratios (95% confidence intervals)


Disclosure: T. Furuya, UCB, 8,Bristol-Myers Squibb, 8,Takeda, 8,Eisai, 8,Chugai, 8,Pfizer Inc, 8,Ono, 8,Asahi Kasei, 8; E. Inoue, None; S. Maeda, None; E. Tanaka, Abbvie, 8,Abumi, 8,Bristol-Myers Squibb, 8,Chugai, 8,Eisai, 8,Nippon Kayaku, 8,Pfizer Inc, 8,Takeda, 8,UCB, 8; K. Ikari, Bristol-Myers Squibb, 8,Abbvie, 8,Eisai, 8,Asahi Kasei, 8,Asttelas, 8,Chugai, 8,Hisamitsu, 8,Janssen Pharmaceutica Product, L.P., 8,Taisho Toyama, 8,Takeda, 8,Santen, 8,Tanabe-Mitsubishi, 8,Kaken, 8; A. Nakajima, Nippon-Kayaku, 5,Bristol-Myers Squibb, 8,Chugai, 8,Novartis Pharmaceutical Corporation, 8,Pfizer Inc, 8,Siemens, 8,Tanabe-Mitsubishi, 8; A. Taniguchi, Pfizer Inc, 8; H. Yamanaka, MSD, 2,Astellas, 2,AbbVie, 2,BMS, 2,Kaken, 2,UCB, 2,Ono, 2,Ayumi, 2,Eisai, 2,Daiichi-Sankyo, 2,Takeda, 2,Tanabe-Mitsubishi, 2,Chugai, 2,NIpponshinyaku, 2,Pfizer Inc, 2,Pfizer Inc, 8,YL biologics, 8,Takeda, 8,NIpponkayaku, 8,Chugai, 8,Tanabe-Mitsubishi, 8,Daiichi-Sankyo, 8,Astellas, 8.

To cite this abstract in AMA style:

Furuya T, Inoue E, Maeda S, Tanaka E, Ikari K, Nakajima A, Taniguchi A, Yamanaka H. Gingival Bleeding and Periodontitis in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Cohort Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/gingival-bleeding-and-periodontitis-in-japanese-patients-with-rheumatoid-arthritis-results-from-the-iorra-cohort-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gingival-bleeding-and-periodontitis-in-japanese-patients-with-rheumatoid-arthritis-results-from-the-iorra-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology